Expired activity
Please go to the PowerPak homepage and select a course.

Practical Considerations When Adding a GLP-1 RA to Background Glucose-Lowering Therapy to Improve Cardiovascular Outcomes: Case Discussion (Part 2 of a 2-Part Podcast Series)

» References (PDF)

FACULTY

Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES
Vice Chair & Allen I. White Distinguished Associate Professor, Pharmacotherapy
Washington State University
Spokane, WA

Jennifer Trujillo, PharmD, FCCP, BCPS, CDCES, BC-ADM
Professor, Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Aurora, CO
Clinical Pharmacist and Certified Diabetes Care and Education Specialist
UCHealth Diabetes and Endocrinology Clinic
Anschutz Medical Campus
Aurora, CO

Heather P. Whitley, PharmD, BCPS, CDCES
Clinical Professor, Pharmacy Practice
Auburn University Harrison School of Pharmacy
Auburn, AL 
Clinical Pharmacy Specialists
Baptist Family Medicine, Baptist Health System
Montgomery, AL

Upon completion of this program, participants should be better able to:

  • Discuss use of GLP-1 RAs to mitigate cardiovascular risk in patients with T2D
  • Describe strategies for adjusting background glucose-lowering therapies in consideration of medication- and patient-specific factors

Back to Top